FDA Approves Pirtobrutinib for Previously Untreated Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma
The FDA approved pirtobrutinib for untreated chronic lymphocytic leukemia and small lymphocytic lymphoma without 17p deletion.
ALL ABOUT DAILYZ HEALTH NEWS
ALL ABOUT DAILYZ HEALTH NEWS
A medical worker collects a swab sample from a woman at a COVID-19 testing site in New York, the United
Read MoreADD TOPIC TO EMAIL ALERTS Receive an email when new articles are posted on Please provide your email address to
Read MoreInvestors are ignoring a huge subsection of tech because it’s considered “taboo” – despite the fact that it is set
Read MoreSource/Disclosures Disclosures: Becerra and Brooks-LaSure reports no relevant financial disclosures. ADD TOPIC TO EMAIL ALERTS Receive an email when new
Read MoreTwo summers ago, a teenager who had jumped off the diving board started struggling in the deep end, her arms
Read MoreFor more than 20 years, the National Eating Disorders Association has operated a phone line and online platform for people
Read MoreSource/Disclosures Disclosures: Bajema reports that all funding for the study was provided by the VA Office of Research and Development.
Read MoreFrancis deSouza, chief executive officer of Illumina Inc., during a panel session on day three of the World Economic Forum
Read MoreADD TOPIC TO EMAIL ALERTS Receive an email when new articles are posted on Please provide your email address to
Read MoreSource/Disclosures Disclosures: Baden, Hunsberger, Jackson, Kotloff and Perez report no relevant financial disclosures. ADD TOPIC TO EMAIL ALERTS Receive an
Read More